LYKA LABS LTD. - 500259 - Shareholding for the Period Ended June 30, 2019
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here20-07-2019
LYKA LABS LTD. - 500259 - Shareholding for the Period Ended June 30, 2019
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click hereLyka Labs Ltd - 500259 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Raj TrivediDesignation :- Company Secretary and Compliance OfficerLyka Labs Ltd - 500259 - Announcement under Regulation 30 (LODR)-Demise
We regret to inform you about the sudden and sad demise of Shri. Narendra Ishwarlal Gandhi, Chairman and Managing Director of Lyka Labs Limited ("the Company") on Wednesday, 10th July, 2019. Shri. Narendra Ishwarlal Gandhi was associated with the Company since it''s incorporation in 1976 and the Company has been immensely benefited from his vision and leadership. All the Directors and employees of the Company convey deep sorrow and condolences to his family. Kindly take the above information on your record.Lyka Labs Ltd - 500259 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 30th June, 2019, received form M/s Sharex Dynamic (India) Pvt. Ltd, Registrar and Share Transfer Agent of the Lyka Labs Limited. This is for your information and Record.LYKA LABS LTD. - 500259 - Closure of Trading Window
Pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider Trading) Regulation, 2015, we wish to inform that the trading window for dealing in the equity shares of the Company for designated persons and their immediate relatives shall remain closed with effect from 1st July, 2019 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended 30th June, 2019 (both days inclusive). This is for your information and records.Lyka Labs Ltd - 500259 - Disclosures Of Related Party Transactions For The Half Year Ended On 31St March, 2019
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure on Related Party Transaction on Consolidated basis for the Half Year ended on 31st March,2019.LYKA LABS LTD. - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendra I Gandhi (HUF)Lyka Labs Ltd - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kunal N GandhiLYKA LABS LTD. - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendra I GandhiLyka Labs Ltd - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narendra I Gandhi (HUF)